| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 05/01/2026 | ±1.4% | +4.0% | under-priced |
| 02/12/2026 | ±1.6% | -2.1% | under-priced |
| 10/31/2025 | ±2.0% | +1.4% | over-priced |
| 08/06/2025 | ±2.4% | -0.2% | over-priced |
| 05/08/2025 | ±2.0% | +0.0% | over-priced |
| 02/13/2025 | ±1.6% | +1.1% | over-priced |
| 10/30/2024 | ±1.4% | +1.2% | over-priced |
| 08/01/2024 | ±2.3% | +1.0% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.81 | $341M | $159M |
| Q4 FY2024 | — | $388M | $181M |
| Q3 FY2025 | $0.69 | $322M | $62M |
| Q2 FY2025 | $1.78 | $312M | $156M |
FRT (FRT) reports in 1 day, with the next report estimated for 10/28/2026. Across the last 8 reports, options priced an average ±1.8% earnings move while the stock actually moved 1.4% on average — the market has systematically over-priced FRT's earnings risk. Fundamentals into the print: EPS up 151.4% year-over-year, revenue up 10.3%. QuantLogix's live 5-factor engine currently reads FRT as a neutral at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →